BioCentury
ARTICLE | Company News

ActivBiotics, University of Washington deal

August 4, 2003 7:00 AM UTC

ActivBiotics received an exclusive license to the university's patents covering the diagnosis and treatment of arterial chlamydial granuloma. The company said that Chlamydia pneumoniae may cause chron...